10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

Andrew DJ Pearson; Delphine Heenen; Pamela R. Kearns; Anne Goeres; Lynley V. Marshall; Patricia Blanc; Gilles Vassal

doi:10.1016/S1470-2045(18)30105-0

10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

Andrew DJ Pearson, Delphine Heenen, Pamela R. Kearns, Anne Goeres, Lynley V. Marshall, Patricia Blanc, Gilles Vassal

Research output: Contribution to journal › Comment/debate

20 Citations (Scopus)

Original language	English
Pages (from-to)	285-287
Number of pages	3
Journal	The Lancet Oncology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(18)30105-0
Publication status	Published - 1 Mar 2018

Access to Document

10.1016/S1470-2045(18)30105-0

Cite this

@article{040890fe789947a181e8946b2a0b3b1f,

title = "10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers",

author = "Pearson, {Andrew DJ} and Delphine Heenen and Kearns, {Pamela R.} and Anne Goeres and Marshall, {Lynley V.} and Patricia Blanc and Gilles Vassal",

year = "2018",

month = mar,

day = "1",

doi = "10.1016/S1470-2045(18)30105-0",

language = "English",

volume = "19",

pages = "285--287",

journal = "The Lancet Oncology",

issn = "1470-2045",

number = "3",

}

TY - JOUR

T1 - 10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

AU - Pearson, Andrew DJ

AU - Heenen, Delphine

AU - Kearns, Pamela R.

AU - Goeres, Anne

AU - Marshall, Lynley V.

AU - Blanc, Patricia

AU - Vassal, Gilles

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85042621404&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30105-0

DO - 10.1016/S1470-2045(18)30105-0

M3 - Comment/debate

C2 - 29508745

AN - SCOPUS:85042621404

SN - 1470-2045

VL - 19

SP - 285

EP - 287

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -

10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers

Access to Document

Other files and links

Cite this